These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10615718)

  • 41. Is the world paying enough attention to the AIDS epidemic in Ukraine and other Newly Independent States?
    Foley PJ
    Soc Mar Q; 1998; 4(3):7-12. PubMed ID: 12294112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilities.
    Des Jarlais DC; Arasteh K; Semaan S; Wood E
    Curr Opin HIV AIDS; 2009 Jul; 4(4):308-13. PubMed ID: 19532069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years.
    Des Jarlais DC; Arasteh K; Friedman SR
    Subst Use Misuse; 2011; 46(2-3):131-9. PubMed ID: 21303233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.
    Uusküla A; McMahon JM; Kals M; Talu A; Abel-Ollo K; Rüütel K; Des Jarlais DC
    AIDS Behav; 2013 Mar; 17(3):879-88. PubMed ID: 22038080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users.
    Lai A; Bozzi G; Franzetti M; Binda F; Simonetti FR; De Luca A; Micheli V; Meraviglia P; Bagnarelli P; Di Biagio A; Monno L; Saladini F; Zazzi M; Zehender G; Ciccozzi M; Balotta C
    PLoS One; 2016; 11(1):e0146097. PubMed ID: 26752062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia.
    Graw F; Leitner T; Ribeiro RM
    Epidemics; 2012 Jun; 4(2):104-16. PubMed ID: 22664069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union.
    Nabatov AA; Kravchenko ON; Lyulchuk MG; Shcherbinskaya AM; Lukashov VV
    AIDS Res Hum Retroviruses; 2002 Aug; 18(12):891-5. PubMed ID: 12201913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution.
    Aceijas C; Friedman SR; Cooper HL; Wiessing L; Stimson GV; Hickman M
    Sex Transm Infect; 2006 Jun; 82 Suppl 3(Suppl 3):iii10-17. PubMed ID: 16735287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis.
    Ahmed T; Long TN; Huong PT; Stewart DE
    BMC Public Health; 2015 Jan; 15():32. PubMed ID: 25631330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.
    Gyarmathy VA; Neaigus A
    J Urban Health; 2005 Sep; 82(3 Suppl 4):iv101-12. PubMed ID: 16107433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theorizing "Big Events" as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks.
    Friedman SR; Rossi D; Braine N
    Int J Drug Policy; 2009 May; 20(3):283-91. PubMed ID: 19101131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV and risk environment for injecting drug users: the past, present, and future.
    Strathdee SA; Hallett TB; Bobrova N; Rhodes T; Booth R; Abdool R; Hankins CA
    Lancet; 2010 Jul; 376(9737):268-84. PubMed ID: 20650523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug use as a driver of HIV risks: re-emerging and emerging issues.
    El-Bassel N; Shaw SA; Dasgupta A; Strathdee SA
    Curr Opin HIV AIDS; 2014 Mar; 9(2):150-5. PubMed ID: 24406532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
    Santibanez SS; Garfein RS; Swartzendruber A; Purcell DW; Paxton LA; Greenberg AE
    J Urban Health; 2006 Jan; 83(1):86-100. PubMed ID: 16736357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug injectors and dealers in Odessa, Ukraine.
    Booth RE; Kennedy J; Brewster T; Semerik O
    J Psychoactive Drugs; 2003; 35(4):419-26. PubMed ID: 14986870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union.
    Bobkov AF; Lukashov VV; Goudsmit J; Weber JN
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):291-4. PubMed ID: 10710217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.